GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced that it will host a ...

Shares of GH Research climbed after the company said it would provide data from a trial of its drug for treatment-resistant depression. The stock rose 5.2%, to $11.15, in after-hours trading on Friday ...

( MENAFN - EIN Presswire) Spravato® (esketamine) has been approved for use as a standalone treatment for depression, without the requirement of an accompanying antidepressant. Rachel Norris, MD ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

Beyond called off its $40 million investment deal with The Container Store. The parent company of Bed, Bath and Beyond in November cast doubt on the deal, expressing concerns the specialty retailer ...

A new psychedelic-assisted therapy clinic has opened in Edmonton, and psychologists say the field has shown promising results ...

Enveric Biosciences receives notice of allowance from USPTO for its drug candidate EB-003 to treat mental health disorders: Cambridge, Massachusetts Saturday, February 1, 2025, 13 ...

The vagus nerve is a key part of the parasympathetic nervous system influencing bodily functions like heart rate digestion ...

The potential legalization of magic mushrooms is heading to Olympia next week as state lawmakers prepare to hear testimony on two bills ...

The explosion happened shortly before 8 a.m. at The Oxford Center at 165 Kirts Blvd. Police said the boy was found dead ...

The National Agency for Food and Drug Administration and Control (NAFDAC) is essential in protecting the health of Nigerians by guaranteeing the safety, quality, and efficacy of various products that ...

The National Agency for Food and Drug Administration and Control (NAFDAC) is essential in protecting the health of Nigerians by guaranteeing the safety, quality ...